#Affix Labs #Repeltec #Green Chemtech

Affix Labs: Pioneering Sustainable Insect Repellent in Europe

Affix Labs Group B.V., a groundbreaking startup in the Green Chemtech sector from the Netherlands, has successfully raised €1 million in a funding round led by VP Capital and Oost NL. This investment aims to accelerate the market launch of their flagship product, Repeltec, a revolutionary water-based insect repellent designed to replace neurotoxic ingredients known to exacerbate insect resistance.

Innovation at its Core

The unique selling point of Repeltec lies in its patented formulation method. This innovative technique allows oily and insoluble active ingredients to be incorporated into water-based systems. Furthermore, Repeltec features a controlled-release layer that ensures effectiveness for up to twelve weeks, making it a long-lasting solution without the risks associated with neurotoxins. Dermatologically tested, Repeltec prioritizes safety for both users and the environment, offering a promising alternative amidst increasing regulatory pressures from the EU on chemical pesticides.

Responding to Regulatory Changes

In the face of tighter EU pesticide regulations, which have already led to bans on several neurotoxic insecticides in various member states, Affix Labs is strategically positioning itself. Germany's self-service ban projected for 2025 is just one example of how legislation is shifting the landscape for pest control products. Repeltec already holds regulatory approvals in Germany, France, Austria, and Norway, paving the way for broader market acceptance.

Expanding Market Reach

With the newly acquired funds, Affix Labs plans to enhance its distribution networks across Germany, Austria, France, and Norway, with future expansions into the UK and Poland. In addition to direct consumer sales, the company is launching a White-Label B2B model under the brand name